ArticleOncotarget2015

PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.

Valentina Zuco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.